Cerebral Edema
31
2
3
14
Key Insights
Highlights
Success Rate
82% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
9.7%
3 terminated out of 31 trials
82.4%
-4.2% vs benchmark
10%
3 trials in Phase 3/4
50%
7 of 14 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 14 completed trials
Clinical Trials (31)
A Trial of Adacolumn on Cerebral Edema After Anterior Circulation Ischemic Stroke
Implementation of Neuro Lung Protective Ventilation
Wet and Dry Biomarkers to Predict Secondary Injury in Stroke: From Bench to Bedside - The NIMBLE Study
Trial of Dexamethasone for Traumatic Brain Injured Patients With Brain Contusions and Pericontusional Edema
Early Prophylactic Decompressive Hemicraniectomy Following Endovascular Therapy in Large Hemispheric Infarct Trial
AI Assisted Reader Evaluation in Acute Computed Tomography (CT) Head Interpretation
High-volume Versus Standard Volume Plasma Exchange in Patients With Acute Liver Failure With Cerebral Edema
Fingolimod as a Treatment of Cerebral Edema After Intracerebral Hemorrhage
Clinical Significance of DKK2 Protein in Cerebral Ischemia-reperfusion Injury
The Tolerability, Safety, and PK Characteristics of SIM1910-09 in Healthy Chinese Volunteers
Safety and Efficacy of ABX-101 in Participants Aged 18 to 50 Years of Age With Moderate to Severe Traumatic Brain Injury
Inflammation and Coagulation Factors for Predicting Cerebral Edema After SAH
Study on Data Acquisition and Image Characteristics of Brain Multifrequency EIT in Healthy People and Patients With Brain Diseases
Acute Ischaemic STROKE: From LAboratory to the Patient's BED
Glyburide vs Placebo as Prophylaxis Against Cerebral Edema in Patients Receiving Radiosurgery for Brain Metastases (RAD 1502/UAB 1593)
Noninvasive Monitoring of Cerebral Blood Flow Autoregulation
Conventional Hemodialysis Versus Post-Dilution Hemofiltration in Incident RRT
Antisecretory Factor in Primary Glioblastoma 1
Coagulation Activation by Hyperosmolar Agents in Intracranial Hypertension
Conivaptan for the Reduction of Cerebral Edema in Intracerebral Hemorrhage- A Safety and Tolerability Study